1. Home
  2. NTSK vs BLLN Comparison

NTSK vs BLLN Comparison

Compare NTSK & BLLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Netskope Inc.

NTSK

Netskope Inc.

HOLD

Current Price

$14.50

Market Cap

3.8B

Sector

Technology

ML Signal

HOLD

Logo BillionToOne Inc.

BLLN

BillionToOne Inc.

N/A

Current Price

$96.02

Market Cap

4.6B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
NTSK
BLLN
Founded
2012
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Medical Specialities
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.8B
4.6B
IPO Year
2025
2025

Fundamental Metrics

Financial Performance
Metric
NTSK
BLLN
Price
$14.50
$96.02
Analyst Decision
Strong Buy
Buy
Analyst Count
17
7
Target Price
$18.19
$126.71
AVG Volume (30 Days)
3.9M
801.1K
Earning Date
03-11-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
12.64
103.40
EPS
N/A
0.48
Revenue
$708,997,000.00
$305,112,000.00
Revenue This Year
$25.76
$46.29
Revenue Next Year
$22.02
$30.14
P/E Ratio
N/A
$197.98
Revenue Growth
31.72
99.97
52 Week Low
$7.67
$61.96
52 Week High
$24.98
$150.44

Technical Indicators

Market Signals
Indicator
NTSK
BLLN
Relative Strength Index (RSI) 54.53 39.80
Support Level $14.23 $81.73
Resistance Level $15.02 $97.36
Average True Range (ATR) 0.81 6.10
MACD -0.11 -2.07
Stochastic Oscillator 35.31 12.34

Price Performance

Historical Comparison
NTSK
BLLN

About NTSK Netskope Inc.

Netskope Inc is redefining the security and networking of cloud and AI. The company has formed a cloud-native platform that offers converged security, networking services, and analytics technology stack to enable fast and secure AI, cloud, and web access at the edge. The products of the company include Netskope One SASE, Netskope One SSE, Cloud Access Security Broker (CASB), Next Generation Secure Web Gateway (SWG), Private Access, Cloud Firewall, SD-WAN, SkopeAI, and others.

About BLLN BillionToOne Inc.

BillionToOne Inc is a molecular diagnostics company. It offers a portfolio of ultrasensitive tests covering prenatal genetic testing, cancer therapy selection, and response monitoring, which are based on its Quantitative Counting Templates (QCT) molecular counting platform. The company's product portfolio comprises UNITY, a portfolio of prenatal testing products that can conduct fetal risk analysis without requiring a paternal sample; Northstar Select, a ultrasensitive liquid biopsy test that provides insights into appropriate therapies for stage III or IV cancer patients; and Northstar Response, a tissue-free, pan-cancer, liquid biopsy test that measures several genomic loci uniquely methylated in cancer to provide insight into dynamic changes in therapy response.

Share on Social Networks: